Skip to main content
Top
Published in: Endocrine 3/2015

01-12-2015 | Original Article

Effects of soy phytoestrogens on pituitary-ovarian function in middle-aged female rats

Authors: Ivana M. Medigović, Jasmina B. Živanović, Vladimir Z. Ajdžanović, Aleksandra L. Nikolić-Kokić, Sanja D. Stanković, Svetlana L. Trifunović, Verica Lj. Milošević, Nataša M. Nestorović

Published in: Endocrine | Issue 3/2015

Login to get access

Abstract

The aim of this study was to assess the effects of genistein (G) and daidzein (D) on the histological, hormonal, and functional parameters of the pituitary-ovarian axis in middle-aged female rats, and to compare these effects with the effects of estradiol (E), commonly used in the prevention and treatment of menopausal symptoms. Middle-aged (12 month old) Wistar female rats subcutaneously received 35 mg/kg of G, or 35 mg/kg of D, or 0.625 mg/kg of E every day for 4 weeks. Each of the treated groups had a corresponding control group. An intact control group was also established. G and D did not change the intracellular protein content within gonadotropic and lactotropic cells, but vacuolization was observed in all the cell types. In contrast, E caused an inhibition of gonadotropic and stimulation of lactotropic cells. Also, ovaries of middle-aged female rats exposed to G or D have more healthy primordial and primary follicles and less atretic follicles. E treatment in the ovaries had a mostly negative effect, which is reflected by the increased number of atretic follicles in all tested classes. G and D provoked decrease in CuZnSOD and CAT activity, while E treatment increased MnSOD and decreased CuZnSOD and GSHPx activity. All the treatments increased serum estradiol and decreased testosterone levels, while D and E increased the serum progesterone level. In conclusion, soy phytoestrogens exhibited beneficial effects on pituitary-ovarian function in middle-aged female rats, as compared to estradiol.
Literature
1.
go back to reference M. Guida, F. Zullo, B. Buonomo, M.L. Marra, V. Palatucci, R. Pascale, F. Visconti, G. Guerra, M. Spinelli, A. Di Spiezio Sardo, Estrogens and neuropeptides in postmenopausal women, un update. Transl. Med. UniSa 3, 25–41 (2012)PubMedCentralPubMed M. Guida, F. Zullo, B. Buonomo, M.L. Marra, V. Palatucci, R. Pascale, F. Visconti, G. Guerra, M. Spinelli, A. Di Spiezio Sardo, Estrogens and neuropeptides in postmenopausal women, un update. Transl. Med. UniSa 3, 25–41 (2012)PubMedCentralPubMed
2.
go back to reference A. Cagnacci, M. Cannoletta, F. Palma, R. Zanin, A. Xholli, A. Volpe, Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. Climacteric 15, 157–162 (2012)CrossRefPubMed A. Cagnacci, M. Cannoletta, F. Palma, R. Zanin, A. Xholli, A. Volpe, Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. Climacteric 15, 157–162 (2012)CrossRefPubMed
3.
go back to reference A.J. Welton, M.R. Vickers, J. Kim, D. Ford, B.A. Lawton, A.H. Maclennan, S.K. Meredith, J. Martin, T.W. Meade, Health related quality of life after combined hormone replacement therapy randomised controlled trial. BMJ 337, a1190 (2008)PubMedCentralCrossRefPubMed A.J. Welton, M.R. Vickers, J. Kim, D. Ford, B.A. Lawton, A.H. Maclennan, S.K. Meredith, J. Martin, T.W. Meade, Health related quality of life after combined hormone replacement therapy randomised controlled trial. BMJ 337, a1190 (2008)PubMedCentralCrossRefPubMed
4.
go back to reference J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene, Writing Group for the Women’s Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results. From the Women’s Health Initiative randomized controlled trial. JAMA 288, 321–333 (2002)CrossRefPubMed J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene, Writing Group for the Women’s Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results. From the Women’s Health Initiative randomized controlled trial. JAMA 288, 321–333 (2002)CrossRefPubMed
5.
go back to reference L.L. Schierbeck, L. Rejnmark, C.L. Tofteng, L. Stilgren, P. Eiken, L. Mosekilde, L. Køber, J.E. Jensen, Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women, randomised trial. BMJ 345, e6409 (2012)CrossRefPubMed L.L. Schierbeck, L. Rejnmark, C.L. Tofteng, L. Stilgren, P. Eiken, L. Mosekilde, L. Køber, J.E. Jensen, Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women, randomised trial. BMJ 345, e6409 (2012)CrossRefPubMed
6.
go back to reference J.E. Manson, R.T. Chlebowski, M.L. Stefanick, A.K. Aragaki, J.E. Rossouw, Anderson G. PrenticeRL, B.V. Howard, C.A. Thomson, A.Z. LaCroix, J. Wactawski-Wende, R.D. Jackson, M. Limacher, K.L. Margolis, S. Wassertheil-Smoller, S.A. Beresford, J.A. Cauley, C.B. Eaton, M. Gass, J. Hsia, K.C. Johnson, C. Kooperberg, L.H. Kuller, C.E. Lewis, S. Liu, L.W. Martin, J.K. Ockene, M.J. O’Sullivan, L.H. Powell, M.S. Simon et al., Menopausal hormone therapy and health outcomes during theintervention and extended poststopping phases of the Women’s HealthInitiative randomized trials. JAMA 310, 1353–1368 (2013)CrossRefPubMed J.E. Manson, R.T. Chlebowski, M.L. Stefanick, A.K. Aragaki, J.E. Rossouw, Anderson G. PrenticeRL, B.V. Howard, C.A. Thomson, A.Z. LaCroix, J. Wactawski-Wende, R.D. Jackson, M. Limacher, K.L. Margolis, S. Wassertheil-Smoller, S.A. Beresford, J.A. Cauley, C.B. Eaton, M. Gass, J. Hsia, K.C. Johnson, C. Kooperberg, L.H. Kuller, C.E. Lewis, S. Liu, L.W. Martin, J.K. Ockene, M.J. O’Sullivan, L.H. Powell, M.S. Simon et al., Menopausal hormone therapy and health outcomes during theintervention and extended poststopping phases of the Women’s HealthInitiative randomized trials. JAMA 310, 1353–1368 (2013)CrossRefPubMed
7.
go back to reference A. Lagro-Janssen, M.W. Knufing, L. Schreurs, C. van Weel, Significant fall in hormone replacement therapy prescription in general practice. Fam. Pract. 27, 424–429 (2010)CrossRefPubMed A. Lagro-Janssen, M.W. Knufing, L. Schreurs, C. van Weel, Significant fall in hormone replacement therapy prescription in general practice. Fam. Pract. 27, 424–429 (2010)CrossRefPubMed
8.
go back to reference M. Bedell, The pros and cons of plant estrogens for menopause. J. Steroid Biochem. Mol. Biol. 139, 225–236 (2014)CrossRefPubMed M. Bedell, The pros and cons of plant estrogens for menopause. J. Steroid Biochem. Mol. Biol. 139, 225–236 (2014)CrossRefPubMed
9.
go back to reference V.S. Lagari, S. Levis, Phytoestrogens for menopausal bone loss and climacteric symptoms. J. Steroid Biochem. Mol. Biol. 139, 294–301 (2014)CrossRefPubMed V.S. Lagari, S. Levis, Phytoestrogens for menopausal bone loss and climacteric symptoms. J. Steroid Biochem. Mol. Biol. 139, 294–301 (2014)CrossRefPubMed
10.
go back to reference G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. Van Der Saag, B. Van Der Burg, J. Gustafsson, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252–4263 (1998)PubMed G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. Van Der Saag, B. Van Der Burg, J. Gustafsson, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252–4263 (1998)PubMed
11.
go back to reference V. Ajdžanović, I. Medigović, J. Zivanović, M. Mojić, V. Milošević, Membrane steroid receptor-mediated action of soy isoflavones, tip of the iceberg. J. Membr. Biol. 248, 1–6 (2015)CrossRefPubMed V. Ajdžanović, I. Medigović, J. Zivanović, M. Mojić, V. Milošević, Membrane steroid receptor-mediated action of soy isoflavones, tip of the iceberg. J. Membr. Biol. 248, 1–6 (2015)CrossRefPubMed
12.
go back to reference V.Z. Ajdžanović, I.M. Medigović, J.B. Pantelić, V.L.J. Milošević, Soy isoflavones and cellular mechanics. J. Bioenerg. Biomembr. 46, 99–107 (2014)CrossRefPubMed V.Z. Ajdžanović, I.M. Medigović, J.B. Pantelić, V.L.J. Milošević, Soy isoflavones and cellular mechanics. J. Bioenerg. Biomembr. 46, 99–107 (2014)CrossRefPubMed
13.
go back to reference L. Pilšáková, I. Riečanský, F. Jagla, The physiological actions of isoflavone phytoestrogens. Physiol. Res. 59, 651–664 (2010)PubMed L. Pilšáková, I. Riečanský, F. Jagla, The physiological actions of isoflavone phytoestrogens. Physiol. Res. 59, 651–664 (2010)PubMed
14.
go back to reference E. Poluzzi, C. Piccinni, E. Raschi, A. Rampa, M. Recanatini, P.F. De, Phytoestrogens in postmenopause, the state of the art from a chemical, pharmacological and regulatory perspective. Curr. Med. Chem. 21, 417–436 (2014)PubMedCentralCrossRefPubMed E. Poluzzi, C. Piccinni, E. Raschi, A. Rampa, M. Recanatini, P.F. De, Phytoestrogens in postmenopause, the state of the art from a chemical, pharmacological and regulatory perspective. Curr. Med. Chem. 21, 417–436 (2014)PubMedCentralCrossRefPubMed
15.
go back to reference W.N. Jefferson, E. Padilla-Banks, R.R. Newbold, Disruption of the developing female reproductive system by phytoestrogens, genistein as an example. Mol. Nutr. Food Res. 51, 832–844 (2007)CrossRefPubMed W.N. Jefferson, E. Padilla-Banks, R.R. Newbold, Disruption of the developing female reproductive system by phytoestrogens, genistein as an example. Mol. Nutr. Food Res. 51, 832–844 (2007)CrossRefPubMed
16.
go back to reference I. Medigović, M. Manojlović-Stojanoski, S. Trifunović, N. Ristić, V. Milošević, D. Zikić, N. Nestorović, Effects of genistein on gonadotropic cells in immature female rats. Acta Histochem. 114, 270–275 (2012)CrossRefPubMed I. Medigović, M. Manojlović-Stojanoski, S. Trifunović, N. Ristić, V. Milošević, D. Zikić, N. Nestorović, Effects of genistein on gonadotropic cells in immature female rats. Acta Histochem. 114, 270–275 (2012)CrossRefPubMed
17.
go back to reference I. Medigović, N. Ristić, S. Trifunović, M. Manojlović-Stojanoski, V. Milošević, D. Zikić, N. Nestorović, Genistein affects ovarian folliculogenesis, a stereological study. Microsc. Res. Tech. 75, 1691–1699 (2012)CrossRefPubMed I. Medigović, N. Ristić, S. Trifunović, M. Manojlović-Stojanoski, V. Milošević, D. Zikić, N. Nestorović, Genistein affects ovarian folliculogenesis, a stereological study. Microsc. Res. Tech. 75, 1691–1699 (2012)CrossRefPubMed
18.
go back to reference J. Hsia, R.D. Langer, J.E. Manson, L. Kuller, K.C. Johnson, S.L. Hendrix, M. Pettinger, S.R. Heckbert, N. Greep, S. Crawford, C.B. Eaton, J.B. Kostis, P. Caralis, R. Prentice, Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Women’s Health Initiative Investigators. Arch. Intern. Med. 166, 357–365 (2006)CrossRefPubMed J. Hsia, R.D. Langer, J.E. Manson, L. Kuller, K.C. Johnson, S.L. Hendrix, M. Pettinger, S.R. Heckbert, N. Greep, S. Crawford, C.B. Eaton, J.B. Kostis, P. Caralis, R. Prentice, Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Women’s Health Initiative Investigators. Arch. Intern. Med. 166, 357–365 (2006)CrossRefPubMed
19.
go back to reference M.M. Abdel-Dayem, M.S. Elgendy, Effects of chronic estradiol treatment on the thyroid gland structure and function of ovariectomized rats. BMC Res. Notes 30, 173 (2009)CrossRef M.M. Abdel-Dayem, M.S. Elgendy, Effects of chronic estradiol treatment on the thyroid gland structure and function of ovariectomized rats. BMC Res. Notes 30, 173 (2009)CrossRef
21.
go back to reference I. Medigović, N. Ristić, J. Živanović, B. Šošić-Jurjević, B. Filipović, V. Milošević, N. Nestorović, Diosgenin does not express estrogenic activity, a uterotrophic assay. Can. J. Physiol. Pharmacol. 92, 292–298 (2014)CrossRefPubMed I. Medigović, N. Ristić, J. Živanović, B. Šošić-Jurjević, B. Filipović, V. Milošević, N. Nestorović, Diosgenin does not express estrogenic activity, a uterotrophic assay. Can. J. Physiol. Pharmacol. 92, 292–298 (2014)CrossRefPubMed
23.
go back to reference J.H. Mitchell, P.T. Gardner, D.B. McPhail, P.C. Morrice, A.R. Collins, G.G. Duthie, Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Biochem. Biophys. 360, 142–148 (1998)CrossRefPubMed J.H. Mitchell, P.T. Gardner, D.B. McPhail, P.C. Morrice, A.R. Collins, G.G. Duthie, Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Biochem. Biophys. 360, 142–148 (1998)CrossRefPubMed
24.
go back to reference B. Sosic-Jurjevic, B. Filipovic, V. Milosevic, N. Nestorovic, M. Manojlovic-Stojanoski, B. Brkic, M. Sekulic, Chronic estradiol exposure modulates thyroid structure and decreases T4 and T3 serum levels in middle-aged female rats. Horm. Res. 63, 48–54 (2005)CrossRefPubMed B. Sosic-Jurjevic, B. Filipovic, V. Milosevic, N. Nestorovic, M. Manojlovic-Stojanoski, B. Brkic, M. Sekulic, Chronic estradiol exposure modulates thyroid structure and decreases T4 and T3 serum levels in middle-aged female rats. Horm. Res. 63, 48–54 (2005)CrossRefPubMed
25.
go back to reference S. Trifunović, M. Manojlović-Stojanoski, V. Ajdžanović, N. Nestorović, N. Ristić, I. Medigović, V. Milošević, Effects of genistein on stereological and hormonal characteristics of the pituitary somatotrophs in rats. Endocrine 47, 869–877 (2014)CrossRefPubMed S. Trifunović, M. Manojlović-Stojanoski, V. Ajdžanović, N. Nestorović, N. Ristić, I. Medigović, V. Milošević, Effects of genistein on stereological and hormonal characteristics of the pituitary somatotrophs in rats. Endocrine 47, 869–877 (2014)CrossRefPubMed
26.
go back to reference M. Miler, B. Šošić-Jurjević, N. Nestorović, N. Ristić, I. Medigović, S. Savin, V. Milošević, Morphological and functional changes in pituitary-thyroid axis following prolonged exposure of female rats to constant light. J. Morphol. 275, 1161–1172 (2014)CrossRefPubMed M. Miler, B. Šošić-Jurjević, N. Nestorović, N. Ristić, I. Medigović, S. Savin, V. Milošević, Morphological and functional changes in pituitary-thyroid axis following prolonged exposure of female rats to constant light. J. Morphol. 275, 1161–1172 (2014)CrossRefPubMed
27.
go back to reference H.J. Gundersen, E.B. Jensen, The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147, 229–263 (1987)CrossRefPubMed H.J. Gundersen, E.B. Jensen, The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147, 229–263 (1987)CrossRefPubMed
28.
go back to reference K.A. Dorph-Petersen, J.R. Nyengaard, H.J.G. Gundersen, Tissue shrinkage and unbiased stereological estimation of particle number and size. J. Microsc. 204, 232–246 (2001)CrossRefPubMed K.A. Dorph-Petersen, J.R. Nyengaard, H.J.G. Gundersen, Tissue shrinkage and unbiased stereological estimation of particle number and size. J. Microsc. 204, 232–246 (2001)CrossRefPubMed
29.
go back to reference H.J. Gundersen, Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc. 143, 3–45 (1986)CrossRefPubMed H.J. Gundersen, Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc. 143, 3–45 (1986)CrossRefPubMed
30.
go back to reference M. Manojlović-Stojanoski, N. Nestorović, N. Ristić, S. Trifunović, B. Filipović, B. Šošić-Jurjević, M. Sekulić, Unbiased stereological estimation of the rat fetal pituitary volume and of the total number and volume of TSH cells after maternal dexamethasone application. Microsc. Res. Tech. 73, 1077–1085 (2010)CrossRefPubMed M. Manojlović-Stojanoski, N. Nestorović, N. Ristić, S. Trifunović, B. Filipović, B. Šošić-Jurjević, M. Sekulić, Unbiased stereological estimation of the rat fetal pituitary volume and of the total number and volume of TSH cells after maternal dexamethasone application. Microsc. Res. Tech. 73, 1077–1085 (2010)CrossRefPubMed
31.
go back to reference H.P. Misra, I. Fridovich, The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247, 3170–3175 (1972)PubMed H.P. Misra, I. Fridovich, The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247, 3170–3175 (1972)PubMed
32.
go back to reference A. Claiborne, Assay for catalase in handbook of methods for oxygen radical research (CRC Press, Boca Raton, 1985), pp. 283–284 A. Claiborne, Assay for catalase in handbook of methods for oxygen radical research (CRC Press, Boca Raton, 1985), pp. 283–284
33.
go back to reference D.E. Paglia, W.N. Valentine, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 74–77 (1967) D.E. Paglia, W.N. Valentine, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 74–77 (1967)
34.
go back to reference D. Glatzle, J.P. Vuilleumier, F. Weber, K. Decker, Glutathione reductase test with whole blood a convenient procedure for the assessment of the riboflavin status in humans. Experientia 30, 665–668 (1974)CrossRefPubMed D. Glatzle, J.P. Vuilleumier, F. Weber, K. Decker, Glutathione reductase test with whole blood a convenient procedure for the assessment of the riboflavin status in humans. Experientia 30, 665–668 (1974)CrossRefPubMed
35.
go back to reference O.H. Lowry, N.L. Rosebrough, A.L. Farr, R.I. Randall, Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)PubMed O.H. Lowry, N.L. Rosebrough, A.L. Farr, R.I. Randall, Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)PubMed
36.
go back to reference A. Ferrari, Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. J. Obstet. Gynaecol. Res. 35, 1083–1090 (2009)CrossRefPubMed A. Ferrari, Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. J. Obstet. Gynaecol. Res. 35, 1083–1090 (2009)CrossRefPubMed
37.
go back to reference C.D. Allred, K.F. Allred, Y.H. Ju, T.S. Goeppinger, D.R. Doerge, W.G. Helferich, Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25, 1649–1657 (2004)CrossRefPubMed C.D. Allred, K.F. Allred, Y.H. Ju, T.S. Goeppinger, D.R. Doerge, W.G. Helferich, Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25, 1649–1657 (2004)CrossRefPubMed
38.
go back to reference M. Du, X. Yang, J.A. Hartman, P.S. Cooke, D.R. Doerge, Y.H. Ju, W.G. Helferich, Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice. Carcinogenesis 33, 895–901 (2012)PubMedCentralCrossRefPubMed M. Du, X. Yang, J.A. Hartman, P.S. Cooke, D.R. Doerge, Y.H. Ju, W.G. Helferich, Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice. Carcinogenesis 33, 895–901 (2012)PubMedCentralCrossRefPubMed
39.
go back to reference Y. Liu, L. Hilakivi-Clarke, Y. Zhang, X. Wang, Y.X. Pan, J. Xuan, S.C. Fleck, D.R. Doerge, W.G. Helferich, Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice. Mol. Nutr. Food Res. (2015). doi:10.1002/mnfr.201500028 PubMedCentral Y. Liu, L. Hilakivi-Clarke, Y. Zhang, X. Wang, Y.X. Pan, J. Xuan, S.C. Fleck, D.R. Doerge, W.G. Helferich, Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice. Mol. Nutr. Food Res. (2015). doi:10.​1002/​mnfr.​201500028 PubMedCentral
40.
go back to reference C.R. Anzalone, L.S. Hong, J.K. Lu, P.S. LaPolt, Influences of age and ovarian follicular reserve on estrous cycle patterns, ovulation, and hormone secretion in the Long-Evans rat. Biol. Reprod. 64, 1056–1062 (2001)CrossRefPubMed C.R. Anzalone, L.S. Hong, J.K. Lu, P.S. LaPolt, Influences of age and ovarian follicular reserve on estrous cycle patterns, ovulation, and hormone secretion in the Long-Evans rat. Biol. Reprod. 64, 1056–1062 (2001)CrossRefPubMed
41.
go back to reference M. González, R. Reyes, C. Damas, R. Alonso, A.R. Bello, Estrogen receptor alpha and beta in female rat pituitary cells, an immunochemical study. Gen. Comp. Endocrinol. 155, 857–868 (2008)CrossRefPubMed M. González, R. Reyes, C. Damas, R. Alonso, A.R. Bello, Estrogen receptor alpha and beta in female rat pituitary cells, an immunochemical study. Gen. Comp. Endocrinol. 155, 857–868 (2008)CrossRefPubMed
42.
43.
go back to reference E.A. McGee, A.J. Hsueh, Initial and cyclic recruitment of ovarian follicles. Endocr. Rev. 21, 200–214 (2000)PubMed E.A. McGee, A.J. Hsueh, Initial and cyclic recruitment of ovarian follicles. Endocr. Rev. 21, 200–214 (2000)PubMed
44.
go back to reference A. Agarwal, A. Aponte-Mellado, B.J. Premkumar, A. Shaman, S. Gupta, The effects of oxidative stress on female reproduction, a review. Reprod. Biol. Endocrinol. 10, 49 (2012)PubMedCentralCrossRefPubMed A. Agarwal, A. Aponte-Mellado, B.J. Premkumar, A. Shaman, S. Gupta, The effects of oxidative stress on female reproduction, a review. Reprod. Biol. Endocrinol. 10, 49 (2012)PubMedCentralCrossRefPubMed
46.
go back to reference S.D. Wang, B.C. Chen, S.T. Kao, C.J. Liu, C.C. Yeh, Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. BMC Complement. Altern. Med. 14, 26 (2014)PubMedCentralCrossRefPubMed S.D. Wang, B.C. Chen, S.T. Kao, C.J. Liu, C.C. Yeh, Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. BMC Complement. Altern. Med. 14, 26 (2014)PubMedCentralCrossRefPubMed
47.
go back to reference Y.H. Choi, W.H. Lee, K.Y. Park, L. Zhang, p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91(2), 164–173 (2000)CrossRefPubMed Y.H. Choi, W.H. Lee, K.Y. Park, L. Zhang, p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91(2), 164–173 (2000)CrossRefPubMed
48.
go back to reference M. Yamasaki, S. Fujita, E. Ishiyama, A. Mukai, H. Madhyastha, Y. Sakakibara, M. Suiko, K. Hatakeyama, T. Nemoto, K. Morishita, H. Kataoka, H. Tsubouchi, K. Nishiyama, Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Sci. 98, 1740–1746 (2007)CrossRefPubMed M. Yamasaki, S. Fujita, E. Ishiyama, A. Mukai, H. Madhyastha, Y. Sakakibara, M. Suiko, K. Hatakeyama, T. Nemoto, K. Morishita, H. Kataoka, H. Tsubouchi, K. Nishiyama, Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Sci. 98, 1740–1746 (2007)CrossRefPubMed
49.
go back to reference G. Rimbach, S. De Pascual-Teresa, B.A. Ewins, S. Matsugo, Y. Uchida, A.M. Minihane, R. Turner, K. VafeiAdou, P.D. Weinberg, Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 33, 913–925 (2003)CrossRefPubMed G. Rimbach, S. De Pascual-Teresa, B.A. Ewins, S. Matsugo, Y. Uchida, A.M. Minihane, R. Turner, K. VafeiAdou, P.D. Weinberg, Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 33, 913–925 (2003)CrossRefPubMed
50.
go back to reference K.A. Rasbach, R.G. Schnellmann, Isoflavones promote mitochondrial biogenesis. J. Pharmacol. Exp. Ther. 325, 536–543 (2008)CrossRefPubMed K.A. Rasbach, R.G. Schnellmann, Isoflavones promote mitochondrial biogenesis. J. Pharmacol. Exp. Ther. 325, 536–543 (2008)CrossRefPubMed
51.
go back to reference A.E. Drummond, P.J. Fuller, Ovarian actions of estrogen receptor-β, an update. Semin. Reprod. Med. 30, 32–38 (2012)CrossRefPubMed A.E. Drummond, P.J. Fuller, Ovarian actions of estrogen receptor-β, an update. Semin. Reprod. Med. 30, 32–38 (2012)CrossRefPubMed
52.
go back to reference C. Spuch, Y. Diz-Chaves, D. Pérez-Tilve, F. Mallo, Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures. Endocrine 29, 317–324 (2006)CrossRefPubMed C. Spuch, Y. Diz-Chaves, D. Pérez-Tilve, F. Mallo, Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures. Endocrine 29, 317–324 (2006)CrossRefPubMed
54.
go back to reference V. Milošević, V. Ajdžanović, Pituitary hormone-producing cells after estradiol application in rat models of menopause. Serb. J. Exp. Clin. Res. 15, 115–120 (2014)CrossRef V. Milošević, V. Ajdžanović, Pituitary hormone-producing cells after estradiol application in rat models of menopause. Serb. J. Exp. Clin. Res. 15, 115–120 (2014)CrossRef
55.
go back to reference G.D. Niswender, J.L. Juengel, P.J. Silva, M.K. Rollyson, E.W. McIntush, Mechanisms controlling the function and life span of the corpus luteum. Physiol. Rev. 80, 1–29 (2000)PubMed G.D. Niswender, J.L. Juengel, P.J. Silva, M.K. Rollyson, E.W. McIntush, Mechanisms controlling the function and life span of the corpus luteum. Physiol. Rev. 80, 1–29 (2000)PubMed
Metadata
Title
Effects of soy phytoestrogens on pituitary-ovarian function in middle-aged female rats
Authors
Ivana M. Medigović
Jasmina B. Živanović
Vladimir Z. Ajdžanović
Aleksandra L. Nikolić-Kokić
Sanja D. Stanković
Svetlana L. Trifunović
Verica Lj. Milošević
Nataša M. Nestorović
Publication date
01-12-2015
Publisher
Springer US
Published in
Endocrine / Issue 3/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0691-x

Other articles of this Issue 3/2015

Endocrine 3/2015 Go to the issue